B38.89 Other forms of coccidioidomycosis

Name of the Condition

• Other forms of coccidioidomycosis

Summary

Other forms of coccidioidomycosis represent a category of fungal infections caused by Coccidioides species that do not fall into the acute pulmonary, chronic pulmonary, or meningitis classifications. These infections may involve extrapulmonary sites (e.g., skin, bones, joints) or present with atypical clinical features. The condition can range from localized disease to disseminated infection, with severity influenced by host immune status.

Causes

The infection results from inhaling airborne spores of Coccidioides fungi, which are endemic to arid regions such as the southwestern United States, Mexico, and parts of Central and South America. These spores are released from soil and become airborne during activities that disturb the ground, including construction, farming, or windstorms. Inhalation leads to infection, with potential spread to other organs in susceptible individuals.

Risk Factors

• Residence or travel to endemic regions, especially during dry, dusty seasons.
• Occupational exposure to soil (e.g., farmers, construction workers, archaeologists).
• Immunocompromised states, including HIV/AIDS, organ transplantation, or prolonged corticosteroid use.
• Pregnancy, particularly the third trimester.
• Advanced age.

Symptoms

• Fatigue and malaise.
• Cough, chest pain, or shortness of breath.
• Fever, night sweats, or weight loss.
• Joint pain or skin rash (erythema nodosum).
• Severe cases may involve meningitis, bone lesions, or disseminated infection.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., chest X-ray, MRI, or CT scans), and laboratory testing. Microbiological confirmation may include culture, histopathology, or antigen detection from affected tissues or fluids. Serologic tests (e.g., complement fixation) can support diagnosis, particularly in disseminated cases.

Treatment Options

Treatment depends on disease severity and site involvement. Mild cases may resolve without therapy, while moderate to severe infections require antifungal medications (e.g., fluconazole, itraconazole). Disseminated or critical infections (e.g., meningitis) may necessitate intravenous amphotericin B. Duration of therapy varies, with some cases requiring long-term suppression.

Prognosis and Follow-Up

Prognosis varies by disease extent and host immunity. Most immunocompetent individuals with localized disease recover fully. Disseminated or severe infections, especially in immunocompromised patients, may have prolonged or complicated courses. Follow-up includes monitoring for recurrence, treatment response, and potential complications (e.g., organ dysfunction).

Complications

• Disseminated infection affecting skin, bones, joints, or other organs.
• Chronic pulmonary disease or fibrosis.
• Meningitis or neurological deficits.
• Respiratory failure in severe pulmonary cases.
• Organ damage from prolonged infection.

Lifestyle & Prevention

• Avoid exposure to dust in endemic areas (e.g., wear masks during construction or windstorms).
• Stay indoors during dust storms.
• Use air filtration in high-risk environments.
• Promptly treat underlying immunocompromising conditions.
• Follow local health advisories for endemic regions.

When to Seek Professional Help

Seek care if symptoms persist (e.g., prolonged cough, fever, or unexplained weight loss) or worsen, especially after travel to endemic areas. Immediate medical attention is needed for severe symptoms (e.g., difficulty breathing, confusion, or neurological changes), which may indicate disseminated disease or complications.

Tips for Medical Coders

Document the specific site or manifestation of coccidioidomycosis (e.g., skin, bone, joint) to support code assignment. Include clinical details (e.g., imaging, lab results, or treatment) to confirm the diagnosis and differentiate from other fungal infections. Ensure documentation aligns with the ICD-10-CM coding guidelines for B38.89.